10-Q: Leef Brands Reports Q1 2026 Results, Focus on Wholesale

Leef Brands Inc. reported flat revenue for Q1 2026 compared to Q1 2025, but significantly improved gross profit and operating income due to a strategic shift to wholesale concentrate manufacturing and cost management.

Summary

• Leef Brands Inc. reported net revenue of $9,377,002 for the three months ended March 31, 2026, a slight decrease of 0.2% from $9,398,261 in the same period of 2025.
• Gross profit significantly increased to $4,624,650 (49% margin) in Q1 2026 from $2,073,290 (22% margin) in Q1 2025.
• Operating income was $1,283,667 in Q1 2026, a substantial improvement from an operating loss of $1,907,545 in Q1 2025.
• The company recorded a net loss of $426,253 in Q1 2026, compared to a net income of $265,776 in Q1 2025.
• Cash provided by operating activities was $395,001 in Q1 2026, a significant improvement from cash used of $1,836,212 in Q1 2025.
• The company raised $4.5 million in gross proceeds from the issuance of preferred and common shares in March 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a cautiously optimistic report, with strong operational improvements in gross margin and operating income, but tempered by a net loss and ongoing going concern uncertainties.

Positives

• Significant improvement in gross profit margin to 49% in Q1 2026 from 22% in Q1 2025, driven by the integration of Salisbury Canyon Ranch for biomass supply and disciplined procurement.
• Turnaround from an operating loss to an operating income of $1,283,667 in Q1 2026, attributed to margin expansion and a $639,852 reduction in operating expenses.
• Positive cash flow from operating activities of $395,001 in Q1 2026, a substantial improvement from the prior year's negative cash flow.
• Strengthened liquidity with a cash balance of $5,755,972 and a working capital surplus of $5,888,291 as of March 31, 2026, largely due to a recent equity raise.
• Reduced operating expenses by 16.1% year-over-year, with notable decreases in wages and salaries, legal and professional fees, and advertising and promotion.

Negatives

• Reported a net loss of $426,253 in Q1 2026, a shift from a net income in the prior year period.
• The net loss was primarily driven by a $390,405 expense from the change in fair value of derivative liabilities, compared to a gain in the prior year.
• Increased provision for income taxes to $974,580 in Q1 2026 from $721,113 in Q1 2025.
• Disclosure controls and procedures were found to be ineffective, and deficiencies in internal control over financial reporting were noted due to company size and limited personnel.
• The company continues to have substantial accumulated deficit of $139,803,363.

Risks

• The ongoing prohibition of cannabis under U.S. federal law and potential changes in federal and state laws and regulations pose a significant risk.
• Continued evolution of state and local cannabis regulations in California, New York, Nevada, and other operating jurisdictions.
• Ability to maintain and renew state and local cannabis licenses and permits.
• Management is aware of uncertainties related to events or conditions that may cast substantial doubt upon the entity's ability to continue as a going concern.
• Exposure to commodity price pressure, including ongoing pricing compression in the California wholesale cannabis market.
• Potential volatility of digital asset holdings, specifically Bitcoin.
• The company has covenanted not to acquire any cryptocurrency, other than nominal amounts, for a period of twenty-four months following March 12, 2028.

Future Outlook

The company's strategic focus on higher-margin wholesale concentrate manufacturing, combined with disciplined operating expense management, is expected to position the company for improving operating performance. Management believes this focus, along with disciplined procurement and in-house biomass supply, supports the ongoing trajectory of margin expansion and operating cash flow.

Management Comments

• Management believes that this strategic focus on higher-margin wholesale concentrate manufacturing, combined with disciplined operating expense management, positions the Company for improving operating performance.
• The Company is generating cash from revenues and deploying its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and near term.
• Management does not expect that its disclosure controls and procedures and internal controls over financial reporting will prevent or detect all error and fraud.

Industry Context

StockSavvy.ai notes that Leef Brands' Q1 2026 results reflect a continued strategic shift within the cannabis industry towards more efficient, higher-margin wholesale operations, away from the more volatile consumer packaged goods (CPG) retail market. The reported margin expansion aligns with industry trends favoring scaled manufacturing and supply chain integration to combat pricing pressures.

Comparison to Industry Standards

• Leef Brands' gross margin of 49% in Q1 2026 is a significant improvement and positions it favorably compared to many multi-state operators (MSOs) in the U.S. cannabis market, which often report gross margins in the 30-40% range, especially those with significant retail footprints.
• The company's focus on wholesale concentrates aligns with a segment of the industry that aims to achieve economies of scale, similar to how large-scale chemical or agricultural commodity producers operate, though the regulatory environment adds unique complexities.
• The reported net loss, despite operational improvements, highlights a common challenge in the cannabis sector where high interest expenses, regulatory burdens (like Section 280E in the U.S.), and significant non-cash items (like derivative liability revaluations) can obscure underlying operational profitability.

Corporate Governance

Legal Proceedings

• As of March 31, 2026, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company's operations.
• As of March 31, 2026, there are no proceedings in which any of the Company's directors, officers, or affiliates is an adverse party to the Company or has a material interest adverse to the Company's interest.

Related Party Transactions

• As of March 31, 2026, the Company had related party payables of $1,423,902.
• During Q1 2026, the Company repaid $492,868 related to notes payable and net reduction of related party trade payables.
• Accrued expenses to a farming company owned by a member of management and shareholder totaled approximately $275,000 as of March 31, 2026.
• Micah Anderson, a director and officer, converted $337,400 of accrued liabilities and interest and $644,679.93 of outstanding notes payable into common shares in December 2025.

Stakeholder Impact

• Shareholders: The net loss and ongoing going concern uncertainties may impact investor confidence. However, the improved operational performance and recent equity raise could be viewed positively.
• Creditors: The company's liquidity has improved, but the substantial accumulated deficit and ongoing need for capital may present risks for creditors.
• Employees: Management's focus on operational efficiency and cost management, including wages and salaries, could impact employee compensation and staffing levels.
• Suppliers: The company's improved gross margins suggest better cost management in its supply chain, potentially benefiting suppliers through consistent orders, though pricing pressures remain.

Next Steps

• Expand its CPG retail offering in fiscal 2026.
• Continue to focus on margin expansion and disciplined cost management in its core wholesale concentrate manufacturing business.
• Actively pursue the sale of the cultivation and processing cannabis license located in Clark County, Nevada.

Key Dates

Recommendation

The company shows significant operational improvements with increased gross margins and a return to operating income, driven by a strategic shift to wholesale. However, the persistent net loss, ongoing going concern uncertainties, and ineffective internal controls warrant a cautious approach. The recent capital raise and merger announcement provide some positive momentum, but further evidence of sustained profitability and improved financial controls is needed before considering a stronger recommendation.

Keywords

Leef Brands, 10-Q, Quarterly Report, Cannabis, Wholesale Concentrates, Financial Results, SEC Filing, California, Gross Margin, Operating Income, Net Loss, Equity Financing